Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common ...

Earlier this month, Vice President and presidential nominee Kamala Harris released a report with details about her health and ...

Harris's physician noted that her latest physical exam in April was 'unremarkable.' However, he reported that she has chronic ...

Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to ...

Hives, also known as urticaria, affects about 20% of people at some time during their lives, including U.S. presidential candidate Kamala Harris.

In spite of treatment advances, chronic urticaria continues to impair patients' health-related quality of life (HRQoL) and drive up direct and indirect healthcare costs. As early as 1997 ...

Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to support US regulatory resubmission by year-end; if ...

On Truth Social, former President Donald Trump claimed that VP Kamala Harris' history of urticaria, allergic rhinitis and ...

Results showed treatment with Dupixent significantly reduced itch and urticaria activity (itch and hive) scores from baseline, and a higher proportion of patients achieved well-controlled disease ...

Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of ...